Hahnemann University Hospital’s license has been terminated, the Pennsylvania Department of Health notified the judge overseeing the bankruptcy of the Philadelphia facility, last week, the Philadelphia Inquirer reported. “I am bringing the current situation at Hahnemann to your attention because I am deeply concerned about the state and security of the building and the supplies and equipment it is housing,” Secretary of Health Rachel L. Levine said on Friday in a letter. The hospital discharged its last inpatient in late July after Hahnemann and St. Christopher’s Hospital for Children filed for bankruptcy protection in late June. A joint venture of Tower Health and Drexel University has agreed to buy St. Christopher’s out of bankruptcy for $50 million. It was not immediately clear what the license revocation means for the proposed sale of Hahnemann’s medical residency programs to Thomas Jefferson University Hospitals Inc. for $55 million. Federal Medicare regulators, which oversees such residency programs, have appealed to the U.S. District Court to block the sale.
